Attenuated Mengo virus: a new vector for live recombinant vaccines. - Wikidata - wikimedia - TriplyDB

Attenuated Mengo virus: a new vector for live recombinant vaccines.

Attenuated Mengo virus: a new vector for live recombinant vaccines.

http://www.wikidata.org/entity/Q35839164

about

MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy The encephalomyocarditis virus Characterization of replication-competent hepatitis A virus constructs containing insertions at the N terminus of the polyprotein Mengovirus and encephalomyocarditis virus poly(C) tract lengths can affect virus growth in murine cell culture.In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge.Immunogenicity of recombinant classic swine fever virus CD8(+) T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccination Recombinant Encephalomyocarditis Viruses Elicit Neutralizing Antibodies against PRRSV and CSFV in Mice Mutational analysis of the mengovirus poly(C) tract and surrounding heteropolymeric sequences.Protection against Foot-and-Mouth Disease Virus in Guinea Pigs via Oral Administration of Recombinant Lactobacillus plantarum Expressing VP1.Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus.Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.Expression of foreign proteins by poliovirus polyprotein fusion: analysis of genetic stability reveals rapid deletions and formation of cardioviruslike open reading frames.

P2860

Q28601803-039A1C5E-D953-4BD7-93AB-83633227D05B Q28715925-3A2C7647-AF92-4983-9AA1-A25C6F57181D Q33781995-28B7E781-290A-4470-9F40-57DF30F097D2 Q33801023-13ABB753-D447-46AA-87E2-391656DC1EE1 Q33806244-83F10B75-0FFF-42D4-A056-DD8A66B9FAD9 Q33852720-EE0CC666-CB2B-4CCE-8F31-605CC2763810 Q35196530-B12AF49C-6C8B-4442-B476-9B3D1AB7F8DA Q35530213-D50665AC-80CA-4A23-B27F-0F706F8150C2 Q35744528-04D03F1B-07E8-402B-8FD1-7CE82E079601 Q35857854-D9C9F454-AEFA-4DC7-A8B6-2C2CD774FAB0 Q35858585-C80BAC37-8D38-45A1-B896-A752BE974608 Q36084898-AE488B7C-B269-4BAB-9BA8-71B5D6FC5866 Q36659320-35D3910D-0B0F-42D8-BDBC-DF12451C7D79 Q39577039-2B7F122A-5798-40AD-85E3-B380F241EA39

P2860

Attenuated Mengo virus: a new vector for live recombinant vaccines.

http://www.wikidata.org/entity/Q35839164

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Attenuated Mengo virus: a new vector for live recombinant vaccines.

@ast

Attenuated Mengo virus: a new vector for live recombinant vaccines.

@en

type

label

Attenuated Mengo virus: a new vector for live recombinant vaccines.

@ast

Attenuated Mengo virus: a new vector for live recombinant vaccines.

@en

prefLabel

Attenuated Mengo virus: a new vector for live recombinant vaccines.

@ast

Attenuated Mengo virus: a new vector for live recombinant vaccines.

@en

P1433

Q35839164-62E26783-31D8-4E3A-8D22-FADA93E40699

P1476

Q35839164-F16CDD82-5576-44E1-8F0E-412BDE587C1E

P2093

Q35839164-27A80BEE-8790-4B5B-B8C7-89FB6F61EB04

Q35839164-5519EF0D-649A-48DF-A87C-73E3562B9D3F

Q35839164-639E3383-BCF1-4646-8987-54EBE4707D55

Q35839164-9F155BD1-FA05-4CC5-94BA-93434E26040B

Q35839164-ECEDB21D-3833-4044-917F-CE4DF7B277CC

P2860

Q35839164-0220E3FF-531E-45E1-800E-D9BAB25F3B6B

Q35839164-0EFA8100-2CB2-48B2-AABE-A5830E3DDD36

Q35839164-2CFD43EB-7284-46C3-99B9-C4CF177B8B4D

Q35839164-2DB2A59A-66F1-4D73-A29D-8D1850BD9BBA

Q35839164-47C27E6B-B357-46DE-803B-8701A2483EC2

Q35839164-6327035E-B43B-4221-B748-8D231A990C11

Q35839164-64FEA9D1-9548-46C6-9D58-62A4BECB4C4D

Q35839164-655F1715-6FB4-4202-B843-D96879144C59

Q35839164-72876D55-71BE-4688-B91D-8F5CD8F89729

Q35839164-77A4D503-CC51-436D-B65E-F9C8BFED6C29

P304

Q35839164-7D304483-A8E2-4E01-AB6D-E98E8E5DF533

P31

Q35839164-BDEBE3C6-8C22-456F-B124-2184DDA4096E

P407

Q35839164-3B7AB75B-1FB3-4D63-AE4C-8571FE3ABC2E

P433

Q35839164-E3676E9E-55FF-444A-A103-2E7D1AA8945D

P478

Q35839164-1451068A-9710-43B8-8B21-496D64B6B1B5

P50

Q35839164-8CB4482E-0F60-47EE-82B4-473474C5E355

P577

Q35839164-9E1878A2-A7DC-4901-A787-90F0F66ABEAB

P698

Q35839164-81B1C504-63D9-4DDD-8EC1-CEF7403002B1

P921

Q35839164-00E9EC2D-07D8-4585-BEE5-7D5E52C34E25

P932

Q35839164-1C0AD52E-EA54-42DA-A68C-1A59EE782CA5

P1433

Journal of Virology

P1476

Attenuated Mengo virus: a new vector for live recombinant vaccines

@en

P2093

Altmeyer R

http://www.w3.org/2001/XMLSchema#string

Girard M

http://www.w3.org/2001/XMLSchema#string

Mimic V

http://www.w3.org/2001/XMLSchema#string

Saron MF

http://www.w3.org/2001/XMLSchema#string

Seigneur L

http://www.w3.org/2001/XMLSchema#string

P2860

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120.

Cloning and synthesis of infectious cardiovirus RNAs containing short, discrete poly(C) tracts.

Polioviruses containing picornavirus type 1 and/or type 2 internal ribosomal entry site elements: genetic hybrids and the expression of a foreign gene

Adenovirus-based expression vectors and recombinant vaccines.

Use of random systematic mutagenesis to generate viable human rhinovirus 14 chimeras displaying human immunodeficiency virus type 1 V3 loop sequences.

Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes

A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge.

Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1.

Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity.

P304

3193-3196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Sylvie van der Werf

P577

1995-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7707549

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

P932

189023

http://www.w3.org/2001/XMLSchema#string